Position in ARDX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,820,356
+$2,913,020 QoQ
Shares Held
804,734
+146.0% QoQ
Ownership
0.326%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in ARDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Trexquant Investment LP holds $494,710,504 across 119 Biotechnology names. ARDX ranks #39 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
483,971 | $24,585,726 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
61,760 | $20,434,531 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
277,114 | $17,375,047 | |
| 4 | EXEL |
Exelixis, Inc.
|
390,818 | $16,762,184 | |
| 5 | HRMY |
Harmony Biosciences Holdings, Inc.
|
594,850 | $16,661,748 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
213,645 | $16,042,603 | |
| 7 | CNTA |
Centessa Pharmaceuticals plc
|
390,951 | $15,528,573 | |
| 8 | ASND |
Ascendis Pharma A/S
|
65,517 | $14,985,703 |
All Filings in ARDX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,820,356 | 804,734 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,907,336 | 327,159 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,778,847 | 504,328 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,042,653 | 776,187 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $8,581,369 | 1,747,733 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,594,996 | 906,311 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,404,347 | 203,824 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,524,318 | 205,711 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,582,075 | 353,709 | Shares | Sole | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||